Wells Fargo & Company Teva Pharmaceutical Industries LTD Put Options Transaction History

Wells Fargo & Company

  • $434 Billion
  • Q3 2024

Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$15.81 - $18.96 $2.77 Million - $3.32 Million
175,000 New
175,000 $3.15 Million
Q4 2022

Feb 13, 2023
BUY
$7.95 - $9.48 $1.99 Million - $2.37 Million
250,000 New
250,000 $2.28 Million
Q4 2020

Feb 09, 2021
SELL
$8.61 - $11.04 $6.65 Million - $8.53 Million
-772,500 Reduced 79.43%
200,000 $185,000
Q1 2020

May 14, 2020
BUY
$6.69 - $13.45 $6.51 Million - $13.1 Million
972,500 New
972,500 $1.73 Million

Others Institutions Holding TEVA

# of Institutions
625
Shares Held
573M
Call Options Held
19.6M
Put Options Held
6.77M
View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

TEVA Quotes by TradingView
  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $24.9B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email